Interactions between environment and immune system play an essential role in the aetiology of immunopathologies, including lymphomas. Toll-like receptors (TLR) belong to a group of pattern recognition receptors, with importance for innate immune response and inflammatory processes. Interleukin-10 (IL-10) is a key regulatory cytokine and has been implicated in lymphomagenesis. Functional polymorphisms in these inflammation-associated genes may affect the susceptibility towards lymphoma. To test this hypothesis, we have genotyped DNA of 710 lymphoma cases and 710 controls within the context of a population-based epidemiological study for 11 functionally important single-nucleotide polymorphisms in TLR1, À2, À4, À5, À9, IL10 and IL10 receptor (IL10RA). The IL10RA Ser138Gly variant was underrepresented among lymphoma cases (odds ratio (OR) ¼ 0.81, 95 per cent confidence interval (95% CI) ¼ 0.65-1.02), mainly owing to an inverse association with Hodgkin's lymphoma (HL). The TLR2 À16933T4A variant was associated with a 2.8-fold increased risk of follicular lymphoma (95% CI ¼ 1.43-5.59) and a decreased risk of chronic lymphocytic leukaemia (OR ¼ 0.61, 95% CI ¼ 0.38-0.95). Furthermore, the TLR4 Asp299Gly variant was positively associated with the risk of mucosa-associated lymphoid tissue lymphoma (OR ¼ 2.76, 95% CI ¼ 1.12-6.81) and HL (OR ¼ 1.80, 95% CI ¼ 0.99-3.26). In conclusion, this study suggests an effect of polymorphisms in factors of the innate immune response in the aetiology of some lymphoma subtypes.
Introduction
The incidence of lymphomas has substantially increased over the past decades. 1 The aetiology of lymphoma and the underlying causes for the observed increase are largely unknown; however, genetic and environmental factors involved in immune regulation and inflammation are suspected candidates. 2 This is underlined by a large body of evidence such as (1) the increased risk of lymphoid malignancies among individuals with inherited or acquired immunodeficiencies, 3 (2) the association of some lymphoma subtypes with infectious agents, 4 (3) the correlation with some indicators of the hygiene hypothesis [5] [6] [7] as well as (4) the repeatedly observed inverse association between allergies and asthma and lymphoma risk. 8, 6 The family of Toll-like receptors (TLRs) are important factors mediating the interaction between infectious agents and host immune response and bridging innate and acquired immunity. TLRs are expressed mainly on antigen-presenting cells, including dendritic cells, macrophages/monocytes and B cells, as well as other cells associated with innate immunity. In humans, 10 different TLRs have been identified. 9, 10 They are important pattern recognition receptors of microorganisms. For several TLRs, the binding of different ligands has been demonstrated, allowing the immune system to identify conserved structures as danger signals and initiate an adequate immune response. Some TLR gene variants with potential functional relevance have been associated with various phenotypes including susceptibility to infectious and inflammatory diseases as well as cancer. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] First evidence links a polymorphism in TLR4 (Arg299Gly) with the susceptibility to gastric mucosaassociated lymphoid tissue (MALT) lymphoma. 16 Signalling through TLRs is involved not only in the primary induction of inflammation, however, also antiinflammatory mediators necessary for the resolution of inflammatory processes are activated. 24 Interleukin-10 (IL10) is multifunctional cytokine crucial for the regulation of immune homeostasis 25 and is elevated in lymphomas. 26 Some studies have suggested a role of genetic variants in IL10 in lymphoma aetiology and prognosis. [27] [28] [29] [30] We hypothesized that these factors at the interphase between environment and immune system and important players in inflammatory processes are implicated in lymphomagenesis. Specifically, within our populationbased case-control study on lymphoid neoplasms involving 710 case-control pairs 5, 8 we have explored the contribution of putative functional polymorphisms in TLR1, TLR2, TLR4, TLR5, TLR9, IL10 and interleukin-10 receptor alpha (IL10RA) to inter-individual differences in the susceptibility to lymphoma and lymphoma subtypes ( Table 2) .
Results
Detailed demographic characteristics of the study population have previously been described. 5, 8 Therefore, only a brief description of the age and sex distribution and the availability of blood samples is summarized in Table 1 .
Association of gene variants with lymphoma and specific lymphoma subtypes The genotype distribution for the TLR1 À7202A4G, TLR2 Arg753Gln G4A, TLR2 À16933T4A, TLR4 Asp299Gly A4G, TLR5 Arg392Stop C4T, TLR9 À1486T4C, TLR9 À1237T4C, IL10 À3575T4A, IL10 À1082A4G, IL10RA Ser138Gly A4G and IL10RA Gly330Arg G4A polymorphisms in all lymphoma cases and by lymphoma subtypes (diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), chronic lymphocytic leukaemia (CLL), multiple myeloma (MM), MALT lymphoma, T-cell lymphoma and Hodgkin's lymphoma (HL)) is presented in Table 2 . Genotype distribution among the controls was in Hardy-Weinberg equilibrium for all investigated polymorphisms.
We found a 20% decreased risk of all lymphoma associated with the IL10RA Ser138Gly G-allele and TLR9 À1237 C-allele, which were of borderline statistical significance. None of the other variants revealed a marked association with the risk of all lymphoma subtypes combined. In the subtype-specific analysis, the TLR2 À16933T4A polymorphism showed a strong increased risk of FL among individuals who carried the A-allele (odds ratios (OR) ¼ 2.82, 95 per cent confidence interval (95% CI) ¼ 1. 43-5.59 The TLR4 299G-allele was more prevalent in cases of MALT lymphoma (13.0%), T-cell non-Hodgkin's lymphoma (NHL) (9.1%) and HL (9.0%) compared to controls (5.3%). The respective OR are 2.76 (95% CI ¼ 1.12-6.81), 1.90 (95% CI ¼ 0.75-4.78) and 1.80 (0.99-3.26). The stop-codon variant in TLR5 and the IL10 polymorphisms did not modify the risk of lymphoma nor any of the subtypes. A strong protective effect for HL was seen for the IL10RA Ser138Gly G-allele (OR ¼ 0.51, 95% CI ¼ 0.31-0.84).
Haplotype associations
The two common haplotypes in TLR2 (TLR2 À16933T4A-TLR2 Arg753Gln) were found significantly associated with lymphoma subtypes FL and CLL. For FL, haplotype T-G had haplotype-specific empirical P-value of P ¼ 0.008, and A-G had haplotype-specific empirical P-value of P ¼ 0.006. The global empirical P-value was P ¼ 0.022. For CLL, haplotype-specific empirical P-value for T-G was 0.029 and for A-G 0.038, with empirical global P-value of P ¼ 0.092. For TLR9 (TLR9 À1486T4 C-TLR9 À1237T4C), the haplotype T-C was found associated with CLL with haplotype-specific empirical P-value of P ¼ 0.052, and C-T was found associated with T-NHL with haplotype-specific empirical P-value of P ¼ 0.003. However, the global empirical P-values were not statistically significant (CLL: P ¼ 0.199; T-NHL: P ¼ 0.051). For IL10RA (IL10RA Ser138Gly-IL10RA Gly330Arg), we found an association with MH with the haplotype G-A and a haplotype-specific empirical Pvalue of P ¼ 0.040 (global empirical P-value P ¼ 0.203). No significant haplotype associations were found between the control group and the group of all lymphoma. Also, no haplotype association was found for IL10 between the control group and lymphoma subtypes.
Interaction between TLR2 À16933T4A and IL10RA Ser138Gly polymorphisms In multivariate analyses of FL cases and controls, we found indications for statistical interaction between the TLR2 À16933T4A and the IL10RA Ser138Gly polymorphisms (P-value for interaction ¼ 0.057). The TLR2 À16933T4A A-allele increased the OR for FL only in individuals who were AA homozygotes for the IL10RA Ser138Gly polymorphism (P ¼ 0.0014) ( Table 3 ). In carriers of the G-allele, the TLR2 À16933T4A is not associated with the risk for FL (P ¼ 0.81).
The combined occurrence of the TLR2 À16933T4A Aallele and the IL10RA Ser138Gly AA wild-type genotype was associated with a 24% increased risk for all lymphoma combined (OR ¼ 1.24, 95% CI ¼ 1.00-1.54), largely owing to the strongly elevated risk for FL (OR ¼ 2.41, 95% CI ¼ 1.49-3.88) and to a lesser extent owing to the association with HL (OR ¼ 1.59, 95% CI ¼ 1.02-2.47). None of the other subtypes was affected Variants in TLRs, IL10, IL10RA and lymphoma risk A Nieters et al Table 2 Odds ratios for all lymphoma combined and lymphoma subtypes associated with polymorphisms within TLR1, À2, À4, À5, À9, IL10 and IL10RA among case subjects and control subjects from a lymphoma case-control study in Germany
TLR1 À7202A4G AA 382 (58) 383 (57) 90 (60) 48 (55) 56 (55) 39 (53) 58 (53) 18 (55) TLR2 À16933T4A TT 178 (27) 166 (25) 33 (22) 10 (11) 36 (36) 18 (25) 26 (24) 11 (33) 4 (15) AT 313 (47) 348 (52) 85 (57) 49 (56) 43 (43) 38 (53) 59 (54) 14 (42) 17 (63) AA 173 (26) 154 (23) 30 (20) 28 (32) 21 (21) 16 (22) 25 (23) 8 (24) (8) 47 (7) 11 (7) 5 (6) 7 (7) 4 (5) 7 (6) (12) 67 (10) 20 (13) 8 (9) 8 (8) 8 (11) 9 (8) 2 (6) (38) 21 (24) 28 (28) 27 (37) 42 (38) 7 (21) 10 (37) TC 331 (50) 332 (49) 65 (43) 49 (56) 58 (57) 36 (49) 53 (48) 14 (42) 14 (52) CC 106 (16) 117 (17) 29 (19) 17 (20) 15 (15) 10 (14) 16 (14) 12 ( Table 2 Continued (75) 111 (73) 70 (80) 80 (78) 52 (71) 85 (77) 28 (85) 16 (59) TC 181 (27) 156 (23) 36 (24) 15 (17) 22 (22) 21 (29) 24 (22) 5 (15) 9 (33) CC 11 (2) 15 (2) (32) 211 (32) 39 (27) 32 (37) 33 (33) 18 (25) 38 (35) 12 (39) 8 (30) AG 302 (46) 298 (45) 70 (48) 35 (40) 44 (44) 35 (49) 53 (49) 10 (32) 12 (44) GG 150 (23) 155 (23) 38 (26) 20 (23) 23 (23) 19 (26) 17 (16) 9 (29) (40) 268 (40) 56 (38) 37 (43) 39 (39) 20 (28) 45 (41) 16 (49) 11 (41) TA 306 (46) 302 (45) 69 (47) 33 (38) 50 (50) 39 (54) 56 (50) 10 (30) 11 (41) AA 93 (14) 100 (15) 23 (16) 17 (20) 11 (11) 13 (18) 10 (9) 7 (21) (46) 68 (46) 39 (45) 47 (47) 30 (41) 55 (50) 15 (45) 11 (41) GA 310 (47) 296 (44) 66 (44) 38 (44) 43 (43) 38 (52) 45 (41) 13 (39) 12 (44) AA 66 (10) 65 (10) 15 (10) 10 (11) 10 (10) 5 (7) 10 (9) 
Association with selected other diseases
In previous analyses, we had identified several variables from questionnaire information that were positively or negatively associated with lymphoma risk. 5, 8 For some of these, such as allergies and childhood viral infections, biological rationale is given for an association with the here explored gene variants in TLRs and members of the IL10 family. Therefore, we explored -in the control group -the distribution of variants in TLRs, IL10 and IL10RA in cases of other reported diseases and the respective controls (individuals that did not report that disease). Significant associations with reported allergies were found for the TLR5 stop codon variant and the IL10RA variants (hay fever) ( Table 4 ). The TLR4 299G-allele was highly overrepresented among cases of reported food allergy (OR ¼ 3.08, 95% CI ¼ 1.64-5.81). The same variant conferred a decreased risk of aphthae. Several polymorphisms were associated with a decreased (TLR1-7202A4G, IL10-1082A4G) or increased (IL10RA variants) risk for reported non-B hepatitis. Reported childhood infections (measles and mumps) were associated with variants in TLR9, reported scarlet fever with TLR1 À7202A4G (Table 4) .
Discussion
Factors at the interphase between environment and immune system such as TLRs and IL10 are discussed as risk factors for lymphoid neoplasms and other immune response-related diseases. In this study, none of the IL10 variants was associated with lymphoma risk nor with the risk of any of the subtypes. However, the IL10RA Ser138Gly variant showed a weak association with the risk of all lymphoma combined, mainly owing to the strong protective effect for HL risk. Furthermore, we found an association of some TLR gene variants with specific lymphoma subtypes. Most strongly, the TLR2 À16933T4A polymorphism was inversely associated with the risk of FL, the TLR4 Arg299Gly variant with the risk of MALT lymphoma (Table 2) .
To our knowledge, this is the first study that explored the association of a number of functionally important variants in TLR genes and IL10RA and the risk of lymphoma and different subtypes.
IL10 mediates its biological effects by signalling through the IL10 receptor, a heterotetramer consisting of two dimeric receptor chains, IL10Ra and IL10Rb. 25 Recently, two functionally important non-synonomous polymorphisms have been identified in IL10RA. 31 Homozygosity of the glycine variant of the IL10RA Gly330Arg polymorphism was associated with reduced sensitivity of IL10 and consequently reduced inhibition of tumour necrosis factor-a (TNF-a) production. 31 This variant was recently correlated with hepatic cirrhosis in hepatitis C virus infection. 32 For the second variant (Ser138Gly), structure analyses suggested a potential impact on the conformation of the IL10-IL10RA complex. 31 In our study, this polymorphism was associated with a reduced risk of lymphoma, mainly driven by the 50% risk reduction for HL. It can be speculated that more effective cellular immunity due to suboptimal IL10 signalling is a favourable factor for the pathobiology of HL. For this group of lymphoid neoplasms, an infectious aetiology is suggested. The association of Epstein-Barr virus (EBV) infection with a proportion of cases is well established and also for the non-EBV-associated cases an infectious aetiology is discussed. 33 An imbalanced T-helper (Th)1/ Th2 response in the direction of Th1 may also underlie the positive association of these variants with reported non-B hepatitis and the inverse association with reported hay fever.
The À16933A-allele in TLR2 did show a strong association with the risk of FL, and was underrepresented among individuals with CLL. TLR2 recognizes bacterial-derived molecules (lipoproteins, peptidoglycans and glycolipids) and viral-derived envelope proteins and lipopeptides and cooperates with TLR1 and TLR6. 34 Following the activation of the innate immune response, TLR2 appears to be important for the resolution of inflammation and the generation of a homeostatic balance of the immune system after invasion. 24 Genetic variants in TLR2 may contribute to a shift of this balance and consequently predispose towards immunopathologies. An overly active anti-inflammatory response, for instance, may lead to immunosuppression and persistence of microorganisms in the host. This eventually results in chronic antigen stimulation, a known risk factor for lymphomagenesis. 35, 36 Polymorphisms in TLR2 have been associated with susceptibility to bacterial infection in mice and in humans. 37, 19, 22 The À16933T4A variant has not been analysed functionally; however, it appears to be of clinical relevance. The T-allele has been associated with a decreased risk of asthma, atopic sensitization and current hay fever symptoms among children of farmers, 13, 38 indicating an impact of this variant on immune responsiveness. Host immune response appears to be of particular importance for the clinical course of FL. 39, 40 The strong association of FL risk with the TLR2 À16933T4A variant and some indication for a role of the TLR9 À1486T4C suggests that genes of innate immunity may also be aetiologically relevant. For the TLR2 variant, a 2.8-fold increased risk of FL (P ¼ 0.003) and a 40% decreased risk of CLL (P ¼ 0.03) was presented. At first sight it appears implausible that the same variant shows these opposite associations with lymphoma subtypes. However, it is increasingly recognized that lymphoma subtypes appear to differ in aetiology and molecular pathogenesis. 41, 42 The observed associations could be explained if one assumes that TLR2 modulates the effect of an environmental factor which is a risk factor of FL and slightly protective for CLL. As subsequently discussed, we cannot exclude the possibility that one or both results are chance findings.
We found evidence for a statistical interaction on the multiplicative scale between the TLR2 À16933T4A and IL10RA Ser138Gly variants. TLR2 induces IL10 production and is linked to IL10-mediated immune suppression. [43] [44] [45] Furthermore, TLR2-dependent signals were recently shown to mediate the generation of downmodulating T-regulatory cells, IL10-secreting immune cells with important function in balancing immune response. 46, 44 We hypothesize that under the circumstance of 'enhanced' IL10 sensitivity owing to the IL10RA AAgenotype, the production of TNF-a and further proinflammatory cytokines is decreased, with negative consequences on cellular immunity. Impaired cellular immunity may confer an increased risk of FL owing to the weakened anti-viral and antitumour immune response.
The TLR4 Asp299Gly polymorphism was associated with an elevated risk for MALT lymphoma, HL (borderline nonsignificant) and T-NHL (nonsignificant). This variant attenuates receptor signalling 12, 20 and patients carrying this polymorphism had an increased susceptibility to Gram-negative infections. 17, 47 Furthermore, this variant has been associated with several other infectious and inflammatory conditions. 14,17,22 TLR4 activates several intracellular signalling pathways including the nuclear factor-kB pathway, resulting in the release of inflammatory mediators, anti-microbial peptides and other molecules that link innate and adaptive immunity. Disruption of TLR4 signalling may have negative consequences on the interplay of innate and adaptive immune responses necessary to eradicate pathogens like Helicobacter pylori. Chronic inflammation by H. pylori is implicated in the aetiology of MALT lymphoma 48 and its eradication with antibiotics alone resulted in regression of gastric MALT lymphoma. 48, 49 Evidence from this study and a previous report 16 suggests that TLR4 Asp299Gly variant may be one of the host factors affecting the risk of lymphoma among H. pylori-infected individuals. The variant was underrepresented among cases of gastric MALT lymphoma in a previous study 16 and is positively associated with MALT lymphoma in our study population. Although both study populations have a similar ethnic background, an unmeasured 'causal' mutation might be in linkage disequilibrium with different variants of TLR4 Asp299Gly. The TLR4 Asp299Gly variant is also associated with a threefold increased risk of reported food allergy. Interestingly, in support of our finding, evidence for a greatly heightened susceptibility to allergic response to food antigens has been presented in strains of mice lacking a functional TLR4. 50 However, for the interpretation of our study result it should be emphasized that 'food allergies' were not verified by a clinician, instead we asked each participant for 'physician-diagnosed food allergies'. It cannot be excluded that misclassification has occurred.
CpG DNA from viruses and bacteria is recognized by TLR9 expressed in endosomes. In this study, the association of variants in TLR9 with lymphoma (FL, CLL) is weak. However, we observed a strong association of TLR9 variants with childhood viral infections. Individuals with the TLR9 À1486C-allele were less likely to have reported measles or mumps infection. Both investigated TLR9 single-nucleotide polymorphisms (SNPs) have no known functional effects, but the Callele of the À1237T4C variant was associated with an increased risk of asthma 18 and Crohn's disease. 51 Evidence for a link between measles virus and TLR9 was recently provided. 52 Mice data point towards a critical role of TLR9 in viral sensing.
53,54 TLR1À7202 A4G, previously associated with prostate cancer 23 and TLR5 Arg392Stop, correlated with impaired flagellinmediated signalling 15 did not modulate the risk of lymphoma subtypes. The latter variant was associated with a reduced risk of reported allergies, which seems plausible considering the Th2 eliciting effect of flagellin. 55 The observed associations with subgroups of lymphoma are unlikely owing to population stratification. The study is population-based, 99% of the participants are Caucasians and 485% are of German origin. It cannot be excluded that the observed associations reflect an association with unknown causal variants in tight linkage disequilibrium with the investigated polymorphisms. The statistical power is 485% to identify risk estimates of 1.5 and larger for the combined group of lymphomas. For subtype-specific analysis, however, the study is underpowered and can be considered exploratory in nature. Additionally, owing to multiple testing of multiple SNPs in various strata and for the analysis of interactions between SNPs in IL10RA and TLR2, we cannot exclude that some of the associations may be due to chance. Therefore, replication in independent populations is needed to confirm or refute our findings.
Indicators of the so called 'hygiene hypothesis' such as frequent contact to animals at young age, family size and childhood diseases appear to be correlated also with the risk of lymphoma among adults. [5] [6] [7] It may very well be that TLRs and other factors of the innate immune system as sensors of the environment are crucial factors in mediating these effects. The more in depth investigation of genetic variability in these genes and downstream signalling molecules may also help to bring light into the inverse association between allergies and lymphoma that have repeatedly been reported and that are unexpected on the basis of the hygiene hypothesis.
Materials and methods

Study population
A population-based case-control study was carried out between 1999 and 2002 in six regions of Germany among 18-to 80-year-old adults, 1:1 matched for gender, age ( þ /À1 year of birth) and study region (Table 1) . Details on study design have been published elsewhere. 5, 8 The cases were recruited from hospitals and office-based physicians involved in diagnosis and treatment of lymphoma in the study regions, interviewed by trained interviewers and asked for a 20 ml blood sample. Eligible cases were asked for participation as soon as possible after diagnosis. The median time from diagnosis to interview was 27 days (mean: 38 days). Participation rate was 87.4%. Diagnoses were collected in form of copies of the official pathology or physicians' reports, which were for about 46% of the cases verified by reference pathologists. Additionally, a 10% random sample of all included cases was re-evaluated within a reassessment system in the context of the European collaboration, Epilymph. All cases were classified according to the World Health Organization (WHO) classification system by Jaffé et al. 56 The study comprises 710 case-control pairs (390 male, 320 female subjects) including 554 cases of B-NHL, 158 cases of DLBCL, 92 cases of FL, 104 cases of B-CLL, 76 cases MM, 29 cases of MALT lymphoma, 35 cases of T-NHL and 115 cases of HL. One case was diagnosed as HL and NHL. 8 The controls were drawn randomly from population registers of the study regions which have an almost 100% coverage owing to compulsory registration by law. Participation rate was 44.3% including all people who could not be contacted and who refused participation owing to illness. The response rate was 53.3% excluding these groups. The study was approved by the local ethical committees and written informed consent was obtained from each subject.
Biological samples
Blood was drawn in Vacutainer CPT tubes (Becton Dickinson, NJ, USA) for plasma and lymphocytes and Vacutainer SST tubes (Becton Dickinson) for serum. Blood was taken before therapy for 62% of the cases. From the participants (710 cases, 710 controls), blood specimens were obtained from 96.1% of the patients and 93.5% of the controls. Blood was processed by centrifugation according to the manufacturer's recommendation (Becton Dickinson). Lymphocytes were washed with phosphate-buffered saline, step-wise frozen in foetal calf serum 10% dimethyl sulphoxide solution and stored at À801C. Genomic DNA from lymphocytes was extracted using the QiaAmp Blood kit according to the manufacturer's instructions (Qiagen, Hilden, Germany).
Selection of polymorphisms
The TLR1 À7202 A4G promoter polymorphism alters the putative core binding site of the proto-oncogene PU.1. and was associated with prostate cancer. 23 The TLR2 À16933T4A polymorphism was shown to have an effect on asthma and atopy among farmer's children. 13 The TLR2 Arg753Gln variant was chosen because it was shown to affect the response to bacterial peptides in vitro, 19 and to be associated with several immune pathologies. 11, 21 The TLR4 Asp299Gly variant has been related to hyporesponsiveness to inhaled endotoxins in humans 12, 20 and with several infectious and inflammatory conditions. 14, 17, 9 The TLR5 Arg392Stop variant in the ligand-binding domain abolished flagellin-induced signalling in CHO-K1 cells 57 and was associated with the susceptibility to Legionnaire's disease 15 and systemic Lupus erythematosus. 58 The TLR9 À1237T4C variant was associated with asthma in a European-American study population and in conjunction with the À1486T4C polymorphism differentiates between the most frequent haplotypes. 18 The IL10 À3575 T4A was selected because it affects IL10 production 59 and has a role in lymphomagenesis. 27 The IL10 À1082 A4G polymorphism has been associated with multiple infectious and inflammatory diseases 60 and affects susceptibility and outcome of NHL. 29, 28 For the IL10RA Gly330Arg, IL10-mediated inhibition of TNF-a production in human monocytes was demonstrated. 31 The IL10RA Ser138Gly variant was selected because structural modelling indicated potential conformational changes with potential impact on IL10 signalling. 31 Genotyping Genotyping for TLR2 Arg753Gln was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), 61 genotyping for IL10 À1082A4G by allele-specific PCR. 62 Genotyping of the other variants was performed using Pyrosequencing technology. 63 The respective primers and representative pyrograms are listed in Supplementary Tables 1 and 2 . All PCRs were performed in an Eppendorf Mastercycler (Eppendorf, Hamburg, Germany). PCR mixtures contained 1 Â Reddy Mix PCR buffer (ABgene, Epsom, UK), 1 U of Thermoprime DNA polymerase (ABgene), deoxynucleoside triphosphates (Stratagene, La Jolla, USA each at 250 mM) and primers (each at 1 pmol) in a final volume of 10 ml. Cycling conditions were identical for all investigated polymorphisms: 941C 2 min, 35 Â (941C 40 s, 571C 40 s, 721C 40 s).
Quality control procedures. Pyrosequencing technology provides the sequence of the investigated polymorphisms as well as the surrounding sequence. Therefore, it is a very accurate method to detect SNPs. At least six per cent of the samples were selected at random for repeated genotyping with Pyrosequencing technology or PCR-RFLP, respectively. Furthermore, samples with ambiguous results were repeated. All 96-well plates contained negative (H 2 O) controls, and a set of three positive controls of the respective genotypes (homozygote for allele 1, heterozygote, homozygote for allele 2). For the rare variants, only the first two genotypes were included. For some variants (TLR2 À16933T4A, TLR2 Arg753Gln, IL10 À3575T4A, IL10 À1082A4G), DNA samples with the respective genotype from 102 ethnically diverse individuals were used as positive controls that have been sequenced and genotyped as part of the SNP500Cancer project. 64 
Statistical analysis
All lymphoma subtypes combined were analysed using matched conditional logistic regression taking the matching variables gender, age and study region into account. Owing to sparse data, subentities were analysed by unconditional logistic regression involving all control subjects and using the matching variables for adjustment. Age at diagnosis of the case and age of the control at the time of diagnosis of the respective matched case was taken. Relative risk was estimated by OR and associated 95% CI using the SAS procedure LOGISTIC for unconditional logistic regression.
In a logistic regression model including multiplicative terms, interaction between genes was explored. Evidence of statistical interaction on the multiplicative scale was declared if the difference of the likelihood ratio of the nested model including the main variables and an interaction term and the model including only the main variables was larger than 3.84, corresponding to an alpha level of 0.05 for 1 d.f.
We used the software package Haplo.score 65 to test for association of indirectly deduced haplotypes defined by the SNPs in TLR2, TLR9, IL10 and IL10RA with phenotypes defined by disease status (lymphoma) and lymphoma subtypes. Haplo.score assigns the probability for each haplotype pair consistent with the genotype of an individual by EM algorithm, and then directly models the individual's phenotype as a function of each inferred haplotype pair, weighted by their estimated probability, to account for haplotype uncertainty. Haplo.score provides haplotype-specific association tests as well as a global test. To account for sparse haplotype data, we performed simulations to derive empirical P-values. The number of simulations for empirical P-values was set as 20 000. Haplotype association analysis was adjusted for sex and age.
